Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-23

Clinical Trial Update: Emergency Department Discharge for Type II Supracondylar Fractures - PROSPR Phase 5

View source ↗

Summary

Trial status update indicating the PROSPR Phase 5 study on emergency department discharge for Type II supracondylar humerus fractures is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Supracondylar Fracture | Status: NOT_YET_RECRUITING